BOLT
BOLT BIOTHERAPEUTICS INC
1 day chart
About BOLT
Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of immunotherapies for the treatment of cancer. Its proprietary Boltbody ISAC (immune-stimulating antibody conjugate) platform technology combines tumor-targeting antibodies with immune-stimulating linker payloads to create productive anti-tumor immune responses. This approach creates products that work with a patient’s own immune system, resulting in anti-cancer efficacy with tolerability. Its first Boltbody ISAC is its BDC-1001 program, targeting a tumor antigen, HER2. BDC-1001 completed a dose-escalation trial and is advancing into multiple Phase II clinical trials. BDC-3042, its Dectin-2 agonist antibody program, is being developed to repolarize critical cells in the tumor microenvironment known as tumor-associated macrophages (TAMs) by targeting cell-surface receptors.
Buy US stocks in Australia starting with BOLT. Open an account and start investing today!
$64.28M
-
0.00%
18.8K
$1.75
$1.69
$1.70
$2.72
$1.18
BOLT FAQs
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake Wall St
- Deposit directly into your Stake wallet and you're ready to invest in BOLT
Related Stocks
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.